Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

Objective: The objective of this study was to assess longitudinal change in clinical and dopamine transporter imaging outcomes in early, untreated PD. Methods: We describe 5‐year longitudinal change of the MDS‐UPDRS and other clinical measures using results from the Parkinson's Progression Mark...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mov Disord
Auteurs principaux: Simuni, Tanya, Siderowf, Andrew, Lasch, Shirley, Coffey, Chris S., Caspell‐Garcia, Chelsea, Jennings, Danna, Tanner, Caroline M., Trojanowski, John Q., Shaw, Leslie M., Seibyl, John, Schuff, Norbert, Singleton, Andrew, Kieburtz, Karl, Toga, Arthur W., Mollenhauer, Brit, Galasko, Doug, Chahine, Lana M., Weintraub, Daniel, Foroud, Tatiana, Tosun, Duygu, Poston, Kathleen, Arnedo, Vanessa, Frasier, Mark, Sherer, Todd, Chowdhury, Sohini, Marek, Kenneth
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6001458/
https://ncbi.nlm.nih.gov/pubmed/29572948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27361
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires